Vistagen Therapeutics, Inc.
Recent Filings
All 868 filings →| Form | Description | Date |
|---|---|---|
| 8-K | 8-K | Mar 18, 2026 |
| 8-K | 8-K | Mar 16, 2026 |
| 8-K | 8-K | Mar 11, 2026 |
| 8-K | 8-K | Feb 20, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
| 10-Q | 10-Q | Feb 12, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Prince Joshua S. | Chief Operating Officer | Award / Grant | 4,882 @ $1.70 | 10,863 | Jun 30, 2025 |
| Adler Reid G. | Chief Legal Officer | Award / Grant | 7,541 @ $1.70 | 24,050 | Jun 30, 2025 |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Award / Grant | 6,617 @ $1.70 | 12,801 | Jun 30, 2025 |
| Singh Shawn | President and CEO | Award / Grant | 7,541 @ $1.70 | 18,028 | Jun 30, 2025 |
| Prince Joshua S. | Chief Operating Officer | Award / Grant | 3,310 @ $2.51 | 5,981 | Dec 31, 2024 |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Award / Grant | 2,592 @ $2.51 | 6,184 | Dec 31, 2024 |
| Prince Joshua S. | Chief Operating Officer | Award / Grant | 2,671 @ $2.96 | 2,671 | Jun 28, 2024 |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Award / Grant | 3,592 @ $2.96 | 3,592 | Jun 28, 2024 |
| Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | Award / Grant | 4,854 @ $2.96 | 16,509 | Jun 28, 2024 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Award / Grant | 4,854 @ $2.96 | 10,487 | Jun 28, 2024 |